Actipulse Neuroscience
YC W22Boston, US · Founded 2017 · 38 employees · 2 known investors
Actipulse Neuroscience develops non-invasive brain stimulation technologies using high-frequency magnetic pulses to treat central nervous system disorders, including major depressive disorder and neurodegenerative diseases. The company conducts clinical research on transcranial neuromodulation devices.
BiotechDigital HealthHealthtechMedical DevicesMental Health TechNeurotechnologyMexicoLatin AmericaPartly Remote
Founders & leadership· Y Combinator alumni (W22)
Actipulse Neuroscience was founded in 2017 by Adrien Châtillon and Gabriel Villafuerte.
AC
Adrien ChâtilloninCo-founder · Chairman of the BoardAdrien Châtillon is a founder and CEO of Actipulse Neuroscience, a medical technology company focused on mental health therapeutics. He has previously founded multiple startups and worked internationally across multiple countries.
GV
Gabriel Villafuertein𝕏Co-founder · Chief Medical OfficerGabriel Villafuerte holds an MD/PhD in neuroscience and has self-taught experience in engineering, industrial design, and art. He is developing technology for nervous system disorders at Actipulse Neuroscience.
Investors · 2
In the news
Frequently asked questions
- What does Actipulse Neuroscience do?
- Actipulse Neuroscience develops non-invasive brain stimulation technologies using high-frequency magnetic pulses to treat central nervous system disorders, including major depressive disorder and neurodegenerative diseases. The company conducts clinical research on transcranial neuromodulation devices.
- Who founded Actipulse Neuroscience?
- Actipulse Neuroscience was founded by Adrien Châtillon, Gabriel Villafuerte in 2017.
- Who are Actipulse Neuroscience's investors?
- Actipulse Neuroscience's investors include Y Combinator, FoundersX Ventures.
- Where is Actipulse Neuroscience headquartered?
- Actipulse Neuroscience is headquartered in Boston, US.